🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 786700104
- IPO
- 7/14/2023 · $16.00/share
Business: Sagimet Biosciences Inc. is a a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases resulting from the overproduction of the fatty acid, palmitate.
Company Contact
- CEO
- David Happel
- CFO
- Dennis Hom
- Headquarters
- 155 Bovet Road, Suite 303, San Mateo, CA 94402
- Phone
- 650-561-8600
- Investor Relations
- Robert Uhl, ICR Westwicke · 858-356-5932 · robert.uhl@westwicke.com